The Heart/X
Jul 14, 2025, 12:30
The Heart: Managing Warfarin-Induced Coagulopathy – New Insights into Handling Prolonged INR Levels
The Heart has published on its official X page:
“Management of Prolonged INR (Warfarin-Induced Coagulopathy)”
Effective management of warfarin-induced coagulopathy, characterized by prolonged INR, is crucial to mitigate bleeding risks. Recent updates highlight evidence-based strategies for timely INR reversal, emphasizing a balance between anticoagulation control and patient safety.
More detailed insights on this topic are available at Hemostasis Today.
American Society of Hematology
American Thrombosis and Hemostasis Network
Anticoagulant complications
Bleeding risk reduction
Coagulopathy guidelines
EHA
Emergency anticoagulation care
Hemostasis and Thrombosis Research Society
Hemostasis management
Hemostasis Today
INR reversal strategies
Prolonged INR management
The Heart
Vitamin K antagonists
Warfarin safety
Warfarin-induced coagulopathy
World Federation of Hemophilia
-
Dec 6, 2025, 18:02ASH25 Day 1: Don’t Miss The Highlights
-
Dec 6, 2025, 15:44Atul Gupta on Where The Healthcare Innovation is Headed
-
Dec 6, 2025, 15:22Nathan White on How Inflammation Contributes to Coagulopathy After Trauma
-
Dec 6, 2025, 15:02Anas Younes on AstraZeneca’s Aims in Blood Cancer to Be Presented at ASH25
-
Dec 6, 2025, 14:08David Alderman: ASH25 is Live
-
Dec 6, 2025, 13:53Isabelle Mahé Presents The Proposals from INNOVTE CAT Working Group
-
Dec 6, 2025, 11:50Steve Tuplin on Roche’s Mission at ASH25
-
Dec 6, 2025, 11:13Khaled Musallam on The Lancet Haematology Podcast: Your ASH25 Roadmap
-
Dec 6, 2025, 06:34Akshat Jain: It was Wonderful Hosting and Meeting Industry Leaders on Their Visit Down to Southern California